n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide has been researched along with Torsade de Pointes in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"The ventricular arrhythmia torsade de pointes (TdP) occurs after QT interval prolongation and is associated with sudden cardiac death." | 1.30 | Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits. ( Anderson, ME; Mazur, A; Roden, DM, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kijtawornrat, A | 1 |
Ziolo, MT | 1 |
Nishijima, Y | 1 |
Roche, BM | 1 |
Hamlin, RL | 1 |
Mazur, A | 1 |
Roden, DM | 1 |
Anderson, ME | 1 |
2 other studies available for n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Torsade de Pointes
Article | Year |
---|---|
Effects of sarcolemmal Ca(2+) entry, ryanodine function, and kinase inhibitors on a rabbit model of heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Benzylamines; Disease Models, Animal; Heart Failure; Isoquinolines; | 2010 |
Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |